JPRN-UMIN000010268已完成未知
Topical application of novel anti-microbial peptide, AG30/5C, for cutaneous ulcers - Topical application of AG30/5C for cutaneous ulcers
Medical Center for Translational Research, Osaka University Hospital0 个研究点目标入组 6 人开始时间: 2013年3月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with complication of alcohol and drug intoxication 2. History of malignant tumor 3. Tumor multiplication in ulcer 4. Infection with HIV, HBV, HCV, HTLV-1 5. Pregnancy 6. Osteomyelitis of ulcer 7. Unsuitable patients judged by investigators
研究者
相似试验
已完成
不适用
The use of topical antibacterial skin ointment (TASO) in the management of soft tissue wounds: A randomised controlled trialInjury, Occupational Diseases, Poisoning: Wound healingInjury, Occupational Diseases, PoisoningWound healingISRCTN39666702Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
进行中（未招募）
不适用
Effect of an octenidine-based topical antimicrobial agent (Octenisept) on wound healing of chronic venous leg ulcers: a prospective, twelve-week comparison versus local treatment with Ringer solutionA randomised, double-blind, controlled, parallel-group, multicentre, multinational Phase III b study - not availableEUCTR2006-001855-37-HUSchülke & Mayr GmbH240
进行中（未招募）
不适用
Effect of an octenidine-based topical antimicrobial agent (Octenisept) on wound healing of chronic venous leg ulcers: a prospective, twelve-week comparison versus local treatment with Ringer solutionA randomised, double-blind, controlled, parallel-group, multicentre, multinational Phase III b study - not availableChronic leg ulcersMedDRA version: 9.1Level: LLTClassification code 10066677Term: Chronic leg ulcerEUCTR2006-001855-37-GBSchülke & Mayr GmbH240
进行中（未招募）
不适用
Effect of an octenidine-based topical antimicrobial agent (Octenisept) on wound healing of chronic venous leg ulcers: a prospective, twelve-week comparison versus local treatment with Ringer solutionA randomised, double-blind, controlled, parallel-group, multicentre, multinational Phase III b study - not availableChronic venous leg ulcers In Germany, approximately three million people suffer from chronic leg ulcers of various origins. These ulcers are often very painful and extremely cost-intensive diseases associated with severe reductions of the patients’ quality of life. Vascular ulcers represent 75% of all chronic ulcers in general and are divided into venous (65%) - which is the study indication - and arterial and mixed arterial-venous ulcers (10%).MedDRA version: 9.1Level: LLTClassification code 10066677Term: Chronic leg ulcerEUCTR2006-001855-37-DESchülke & Mayr GmbH240
进行中（未招募）
1 期
Effect of an octenidine-based topical antimicrobial agent (Octenisept) on wound healing of chronic venous leg ulcers: a prospective, twelve week comparison versus local treatment with Ringer solution. A randomised, double-blind, controlled, parallel-group, multicentre, multinational Phase IIIb studyChronic leg ulcersMedDRA version: 9.1Level: LLTClassification code 10066677Term: Chronic leg ulcerEUCTR2006-001855-37-FRSchülke & Mayr GmbH240